Login Register Cart 0
Generic placeholder image

Current Traditional Medicine

Editor-in-Chief

ISSN (Print): 2215-0838
ISSN (Online): 2215-0846

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Efficacy of Herbal Supplementation of Purslane Freeze-dried Juice for Weight Loss: An 8-week Randomized, Double-blind, Placebo-controlled Clinical Trial

Author(s): Mehdi Ajdary Tafti, Mahmoodreza Moein, Siavash Babajafari, Elham Haem and Mohammad M. Zarshenas*

Volume 10, Issue 1, 2024

Published on: 17 April, 2023

Article ID: e280223214170 Pages: 10

DOI: 10.2174/2215083809666230228142552

Price: $65

Abstract

Background: Obesity is a condition that has been linked to several ailments. The current investigation is a randomized, double-blind, placebo-controlled clinical experiment to examine how Portulaca oleracea L. tablets affect hunger and Body Mass Index (BMI).

Methods: A total of 70 healthy people aged 18 - 65 years old with a BMI >25.0 kg/m² were chosen for an 8-week study. They were randomized into two groups, herbal medicine and placebo. Anthropometry, laboratory tests, and appetite assessment by questionnaire were performed at baseline and the end of the study period. In the end, the data were analyzed.

Results: There were significant differences in appetite and BMI (p<0.05) between the two groups after 8 weeks. No serious adverse events occurred in the two groups, and herbal medicine was well tolerated. Purslane juice was found to be well tolerated and could be effective in the reduction of appetite and BMI, either in obese or overweight individuals, following 8 weeks of intervention.

Conclusion: The trial indicated the effectiveness of this extract on appetite and BMI. However, long-term investigations with larger populations are needed to determine the tolerability and permanent effectiveness of this natural medicament.

Graphical Abstract

[1]
Neuhouser ML, Aragaki AK, Prentice RL, et al. Overweight, obesity, and postmenopausal invasive breast cancer risk: A secondary analysis of the women’s health initiative randomized clinical trials. JAMA Oncol 2015; 1(5): 611-21.
[http://dx.doi.org/10.1001/jamaoncol.2015.1546] [PMID: 26182172]
[2]
Ahmad FS, Ning H, Rich JD, Yancy CW, Lloyd-Jones DM, Wilkins JT. Hypertension, obesity, diabetes, and heart failure–free survival: The cardiovascular disease lifetime risk pooling project. JACC Heart Fail 2016; 4(12): 911-9.
[http://dx.doi.org/10.1016/j.jchf.2016.08.001] [PMID: 27908389]
[3]
Steele CB, Thomas CC, Henley SJ, et al. Vital signs: Trends in incidence of cancers associated with overweight and obesity-United States, 2005–2014. MMWR Morb Mortal Wkly Rep 2017; 66(39): 1052-8.
[http://dx.doi.org/10.15585/mmwr.mm6639e1] [PMID: 28981482]
[4]
Kyrou I, Randeva HS, Tsigos C, Kaltsas G, Weickert MO. Clinical problems caused by obesity Endotext MDText com, Inc 2018.
[5]
Zhu Y, Wang Z, Maruyama H, Onoda K, Huang Q. Body fat percentage and normal-weight obesity in the chinese population: Development of a simple evaluation indicator using anthropometric measurements. Int J Environ Res Public Health 2022; 19(7): 4238.
[http://dx.doi.org/10.3390/ijerph19074238] [PMID: 35409919]
[6]
Kushner RF. Obesity and therapeutic approaches to weight lossComprehensive Cardiovascular Medicine in the Primary Care Setting. Springer 2019; pp. 71-85.
[http://dx.doi.org/10.1007/978-3-319-97622-8_4]
[7]
Cebolla A, Barrada JR, van Strien T, Oliver E, Baños R. Validation of the dutch eating behavior questionnaire (DEBQ) in a sample of Spanish women. Appetite 2014; 73: 58-64.
[http://dx.doi.org/10.1016/j.appet.2013.10.014] [PMID: 24177441]
[8]
Nejati V, Alipour F, Saeidpour S, Bodaghi E. Psychometric properties of Persian version of Dutch eating behavior questionnaire. J Fundam Mental Health 2017; 20(1): 5-14.
[http://dx.doi.org/10.13140/RG.2.1.3657.9449]
[9]
Aliasghari F, Jafarabadi MA, Yaghin NL, Mahdavi R. Psychometric properties of power of food scale in Iranian adult population: Gender-related differences in hedonic hunger. Eat Weight Disord 2018; 25(1): 185-93.
[http://dx.doi.org/10.1007/s40519-018-0549-3] [PMID: 30066260]
[10]
Petrin C, Kahan S, Turner M, Gallagher C, Dietz WH. Current practices of obesity pharmacotherapy, bariatric surgery referral and coding for counselling by healthcare professionals. Obes Sci Pract 2016; 2(3): 266-71.
[http://dx.doi.org/10.1002/osp4.53] [PMID: 27708843]
[11]
Kushner RF. Weight loss strategies for treatment of obesity. Prog Cardiovasc Dis 2014; 56(4): 465-72.
[http://dx.doi.org/10.1016/j.pcad.2013.09.005] [PMID: 24438739]
[12]
Kaplan U, Penner S, Farrokhyar F, et al. Bariatric surgery in the elderly is associated with similar surgical risks and significant long-term health benefits. Obes Surg 2018; 28(8): 2165-70.
[http://dx.doi.org/10.1007/s11695-018-3160-9] [PMID: 29525937]
[13]
Douglas IJ, Bhaskaran K, Batterham RL, Smeeth L. Bariatric surgery in the United Kingdom: A cohort study of weight loss and clinical outcomes in routine clinical care. PLoS Med 2015; 12(12): e1001925.
[http://dx.doi.org/10.1371/journal.pmed.1001925] [PMID: 26694640]
[14]
Bessesen DH, Van Gaal LF. Progress and challenges in anti-obesity pharmacotherapy. Lancet Diabetes Endocrinol 2018; 6(3): 237-48.
[http://dx.doi.org/10.1016/S2213-8587(17)30236-X] [PMID: 28919062]
[15]
Sun NN, Wu TY, Chau CF. Natural dietary and herbal products in anti-obesity treatment. Molecules 2016; 21(10): 1351.
[http://dx.doi.org/10.3390/molecules21101351] [PMID: 27727194]
[16]
Brett EM. Pharmacotherapy for weight management Bariatric Endocrinology. Springer 2019; pp. 395-411.
[http://dx.doi.org/10.1007/978-3-319-95655-8_21]
[17]
El-Menshawe S, Ali A, Rabeh M, Khalil N. Nanosized soy phytosome-based thermogel as topical anti-obesity formulation: An approach for acceptable level of evidence of an effective novel herbal weight loss product. Int J Nanomedicine 2018; 13: 307-18.
[http://dx.doi.org/10.2147/IJN.S153429] [PMID: 29391791]
[18]
Srivastava G, Apovian CM. Current pharmacotherapy for obesity. Nat Rev Endocrinol 2018; 14(1): 12-24.
[http://dx.doi.org/10.1038/nrendo.2017.122] [PMID: 29027993]
[19]
Yousefi M, Falahat F. Main strategies for treatment of obesity based on Iranian traditional medicine. Avicenna J Phytomed 2015; 2: 5.
[20]
Iranshahy M, Javadi B, Iranshahi M, et al. A review of traditional uses, phytochemistry and pharmacology of Portulaca oleracea L. J Ethnopharmacol 2017; 205: 158-72.
[http://dx.doi.org/10.1016/j.jep.2017.05.004] [PMID: 28495602]
[21]
El-Sayed MIK. Effects of Portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternative therapy. J Ethnopharmacol 2011; 137(1): 643-51.
[http://dx.doi.org/10.1016/j.jep.2011.06.020] [PMID: 21718775]
[22]
Shobeiri SF, Sharei S, Heidari A, Kianbakht S. Portulaca oleracea L. in the treatment of patients with abnormal uterine bleeding: A Pilot clinical trial. Phytother Res 2009; 23(10): 1411-4.
[http://dx.doi.org/10.1002/ptr.2790] [PMID: 19274703]
[23]
Agha-Hosseini F, Borhan-Mojabi K, Monsef-Esfahani HR, Mirzaii-Dizgah I, Etemad-Moghadam S, Karagah A. Efficacy of purslane in the treatment of oral lichen planus. Phytother Res 2010; 24(2): 240-4.
[http://dx.doi.org/10.1002/ptr.2919] [PMID: 19585472]
[24]
Moradi M-T, Gatreh Samani K, Farrokhi E, Rafieian-Kopaei M, Karimi A. The effects of purslane (Portulaca oleracea L.) on serum level of lipids, lipoproteins and paraoxanase 1 (PON1) activity in hypercholesterolemia patients. Life Sci J 2012; 9(4): 5548-52.
[25]
Kumar BSA, Prabhakarn V, Lakshman K, et al. Pharmacognostical studies of Portulaca oleracea Linn. Rev Bras Farmacogn 2008; 18(4): 527-31.
[http://dx.doi.org/10.1590/S0102-695X2008000400005]
[26]
Zhou Y-X, Xin H-L, Rahman K, Wang S-J, Peng C, Zhang H. Portulaca oleracea L.: A review of phytochemistry and pharmacological effects. BioMed Res Int 2015; 2015: 925631.
[http://dx.doi.org/10.1155/2015/925631] [PMID: 25692148]
[27]
Jung JH, Hwang SB, Park HJ, Jin GR, Lee BH. Antiobesity and antidiabetic effects of Portulaca oleracea powder intake in high-fat diet-induced obese C57BL/6 mice. Evid Based Complement Alternat Med 2021; 2021: 5587848.
[http://dx.doi.org/10.1155/2021/5587848] [PMID: 34257685]
[28]
EI-Serwy E. Abd EI-Hameid M. Influence of sage (Salvia officinalis L.) and Purslane (Portulaca oleracea L.) on weight reduction and some biochemical parameters in rats suffering from obesity. Egypt J Nutr Health 2012; 7(1): 1-16.
[http://dx.doi.org/10.21608/ejnh.2012.4807]
[29]
Hassan HA, El-Gharib NE. Obesity and clinical riskiness relationship: Therapeutic management by dietary antioxidant supplementation-a review. Appl Biochem Biotechnol 2015; 176(3): 647-69.
[http://dx.doi.org/10.1007/s12010-015-1602-6] [PMID: 25864185]
[30]
Aghili SM. Makhzan-ol-advieh . Storehouse of medicaments. In: Tehran, Iran 1771; 1771: pp. 282-723.
[31]
Chaudhary S, Alam M, Singh S, Deuja S, Karmacharya P, Mondal M. Correlation of blood pressure with body mass index, waist circumference and waist by hip ratio. J Nepal Health Res Counc 2019; 16(41): 410-3.
[http://dx.doi.org/10.33314/jnhrc.v16i41.1560] [PMID: 30739931]
[32]
Hendrickson SJ, Mattes RD. No acute effects of grape juice on appetite, implicit memory and mood. Food Nutr Res 2008; 52(1): 1891.
[http://dx.doi.org/10.3402/fnr.v52i0.1891] [PMID: 19158941]
[33]
Sergent T, Vanderstraeten J, Winand J, Beguin P, Schneider Y-J. Phenolic compounds and plant extracts as potential natural anti-obesity substances. Food Chem 2012; 135(1): 68-73.
[http://dx.doi.org/10.1016/j.foodchem.2012.04.074]
[34]
Erkan N. Antioxidant activity and phenolic compounds of fractions from Portulaca oleracea L. Food Chem 2012; 133(3): 775-81.
[http://dx.doi.org/10.1016/j.foodchem.2012.01.091]
[35]
Fernández-Poyatos MP, Llorent-Martínez EJ, Ruiz-Medina A. Phytochemical composition and antioxidant activity of Portulaca oleracea: Influence of the steaming cooking process. Foods 2021; 10(1): 94.
[http://dx.doi.org/10.3390/foods10010094] [PMID: 33466382]
[36]
Lee EM, Lee SS, Chung BY, et al. Pancreatic lipase inhibition by C-glycosidic flavones isolated from Eremochloa ophiuroides. Molecules 2010; 15(11): 8251-9.
[http://dx.doi.org/10.3390/molecules15118251] [PMID: 21081855]
[37]
Nakai M, Fukui Y, Asami S, et al. Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. J Agric Food Chem 2005; 53(11): 4593-8.
[http://dx.doi.org/10.1021/jf047814+] [PMID: 15913331]
[38]
Hosseini A, Razavi BM, Banach M, Hosseinzadeh H. Quercetin and metabolic syndrome: A review. Phytother Res 2021; 35(10): 5352-64.
[http://dx.doi.org/10.1002/ptr.7144] [PMID: 34101925]
[39]
Xu X, Yu L, Chen G. Determination of flavonoids in Portulaca oleracea L. by capillary electrophoresis with electrochemical detection. J Pharm Biomed Anal 2006; 41(2): 493-9.
[http://dx.doi.org/10.1016/j.jpba.2006.01.013] [PMID: 16516429]
[40]
Montoya-García CO, García-Mateos R, Becerra-Martínez E, Toledo-Aguilar R, Volke-Haller VH, Jesús Magdaleno-Villar J. Bioactive compounds of purslane (Portulaca oleracea L.) according to the production system: A review. Sci Hortic 2023; 308: 111584.
[http://dx.doi.org/10.1016/j.scienta.2022.111584]
[41]
Chen IJ, Liu CY, Chiu JP, Hsu CH. Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial. Clin Nutr 2016; 35(3): 592-9.
[http://dx.doi.org/10.1016/j.clnu.2015.05.003] [PMID: 26093535]
[42]
Taghizadeh M, Farzin N, Taheri S, et al. The effect of dietary supplements containing green tea, capsaicin and ginger extracts on weight loss and metabolic profiles in overweight women: A randomized double-blind placebo-controlled clinical trial. Ann Nutr Metab 2017; 70(4): 277-85.
[http://dx.doi.org/10.1159/000471889] [PMID: 28595182]
[43]
Stenblom EL, Egecioglu E, Landin-Olsson M, Erlanson-Albertsson C. Consumption of thylakoid-rich spinach extract reduces hunger, increases satiety and reduces cravings for palatable food in overweight women. Appetite 2015; 91: 209-19.
[http://dx.doi.org/10.1016/j.appet.2015.04.051] [PMID: 25895695]
[44]
Brum JM, Gibb RD, Peters JC, Mattes RD. Satiety effects of psyllium in healthy volunteers. Appetite 2016; 105: 27-36.
[http://dx.doi.org/10.1016/j.appet.2016.04.041] [PMID: 27166077]
[45]
Parandoosh M, Yousefi R, Khorsandi H, Nikpayam O, Saidpour A, Babaei H. The effects of grape seed extract (VITIS VINIFERA) supplement on inflammatory markers, neuropeptide Y, anthropometric measures, and appetite in obese or overweight individuals: A randomized clinical trial. Phytother Res 2020; 34(2): 379-87.
[http://dx.doi.org/10.1002/ptr.6529] [PMID: 31713941]
[46]
Vogels N, Nijs IMT, Westerterp-Plantenga MS. The effect of grape-seed extract on 24 h energy intake in humans. Eur J Clin Nutr 2004; 58(4): 667-73.
[http://dx.doi.org/10.1038/sj.ejcn.1601863] [PMID: 15042136]
[47]
Laleh P, Yaser K, Abolfazl B, et al. Oleoylethanolamide increases the expression of PPAR-A and reduces appetite and body weight in obese people: A clinical trial. Appetite 2018; 128: 44-9.
[http://dx.doi.org/10.1016/j.appet.2018.05.129] [PMID: 29787831]
[48]
Jazayeri-Tehrani SA, Rezayat SM, Mansouri S, et al. The nanocurcumin reduces appetite in obese patients with non-alcoholic fatty liver disease (NAFLD): A double-blind randomized placebo-controlled clinical trial. Nanomed J 2018; 5(2): 67-76.
[49]
Spadafranca A, Rinelli S, Riva A, et al. Phaseolus vulgaris extract affects glycometabolic and appetite control in healthy human subjects. Br J Nutr 2013; 109(10): 1789-95.
[http://dx.doi.org/10.1017/S0007114512003741] [PMID: 23046862]
[50]
Astell KJ, Mathai ML, McAinch AJ, Stathis CG, Su XQ. A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: A randomised controlled clinical trial. Complement Ther Med 2013; 21(3): 180-9.
[http://dx.doi.org/10.1016/j.ctim.2013.01.004] [PMID: 23642949]
[51]
Rao A, Briskey D, dos Reis C, Mallard AR. The effect of an orally-dosed Caralluma Fimbriata extract on appetite control and body composition in overweight adults. Sci Rep 2021; 11(1): 6791.
[http://dx.doi.org/10.1038/s41598-021-86108-2] [PMID: 33762661]
[52]
Dutt HC, Singh S, Avula B, Khan IA, Bedi YS. Pharmacological review of Caralluma R.Br. with special reference to appetite suppression and anti-obesity. J Med Food 2012; 15(2): 108-19.
[http://dx.doi.org/10.1089/jmf.2010.1555] [PMID: 22191633]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy